Babesia divergens glycosylphosphatidylinositols modulate blood coagulation and induce Th2-biased cytokine profiles in antigen presenting cells

This work was supported by the the University of Tours (to IDP and FDG), the University of Montpellier (to SD and EC), the Deutsche Forschungsgemeinschaft (to RTS), the Wellcome Trust project grant 093228 (to TKS) and the Campus France/DAAD PHC PROCOPE 24931RE (to RTS and EC). The funding source has no involvement in the conduct of the research and preparation of the article.Glycosylphosphatidylinositols (GPIs) are glycolipids described as toxins of protozoan parasites due to their inflammatory properties in mammalian hosts characterized by the production of interleukin (IL)-1, IL-12 and tumor necrosis factor (TNF)-α. In the present work, we studied the cytokines produced by antigen presenting cells in response to ten different GPI species extracted from Babesia divergens, responsible for babesiosis. Interestingly, B. divergens GPIs induced the production of anti-inflammatory cytokines (IL-2, IL-5) and of the regulatory cytokine IL-10 by macrophages and dendritic cells. In contrast to all protozoan GPIs studied until now, GPIs from B. divergens did not stimulate the production of TNF-α and IL-12, leading to a unique Th1/Th2 profile. Analysis of the carbohydrate composition of the B. divergens GPIs indicated that the di-mannose structure was different from the evolutionary conserved tri-mannose structure, which might explain the particular cytokine profile they induce. Expression of major histocompatibility complex (MHC) molecules on dendritic cells and apoptosis of mouse peritoneal cells were also analysed. B. divergens GPIs did not change expression of MHC class I, but decreased expression of MHC class II at the cell surface, while GPIs slightly increased the percentages of apoptotic cells. During pathogenesis of babesiosis, the inflammation-coagulation auto-amplification loop can lead to thrombosis and the effect of GPIs on coagulation parameters was investigated. Incubation of B. divergens GPIs with rat plasma ex vivo led to increase of fibrinogen levels and to prolonged activated partial thromboplastin time, suggesting a direct modulation of the extrinsic coagulation pathway by GPIs.Publisher PDFPeer reviewe

Imidazo[1,2-6]pyridazines targeting TgCDPK1 to treat Congenital Toxoplasmosis in mice

International audienc

Glycosylphosphatidylinositols of apicomplexan parasites: a structure-activity relationship analysis

International audienceGlycosylphosphatidylinositols (GPIs) are widespread among eukaryotes, and the expression of GPI-anchored proteins and free GPIs is particularly abundant among the parasitic protozoa. The basic structure of GPIs consists of ethanolamine, mannose, non-acetylated glucosamine, inositol and a lipid-moiety, in part linked by diphosphate bridges. In addition, the evolutionary conserved core structure undergoes species-specific structural variations. The synthesis of GPI anchors takes place in the endoplasmic reticulum and requires many different steps. Protocols used for the identification and characterization of GPIs depend mainly upon sufficient amounts of material or metabolic labelling techniques using radioactive GPI precursor molecules, organic solvent extraction procedures, the use of specific enzymes an of thin-layer chromatography analysis. Responses of host cells to GPIs of apicomplexan parasites (Babesia divergens, Plasmodium falciparum, Neospora caninum, Toxoplasma gondii) have been studied and a structure-activity relationship can be outlined on cytokine production (1-3), Toll-like receptor activation (2-4) and apoptosis (5-6)

Design, synthesis, and evaluation of new inhibitors of Apicomplexa

International audienc

Nanoparticle-based vaccine platforms against apicomplexan

International audienceVaccines based on live attenuated parasites are associated with safety concerns related to reversion to pathogenic form or intracellular apicomplexan parasites will depend on several factors such as selection of appropriate parasite antigens and optimal presentation of these antigens to the immune system, including identification of the best adjuvant formulation and route of vaccine administration. Due to the complexity of apicomplexan parasites, vaccine strategies must associate large panel of antigens and adjuvant able to better stimulate innate and adaptive immune responses than in natural infection. Toll-like receptors are expressed on numerous cells of the immune system and TLR agonists are promising adjuvants also in farm animals. Mucosal administration of vaccines, by mimicking natural route of infection, is an important approach to induce appropriate protective immune responses to microbial antigens in systemic sites and peripheral blood as well as in most mucosal environments. Our team has demonstrated that maltodextrin/phospholipid nanoparticles sustain release of all soluble components of Toxoplasma gondii after nasal administration. This formulation led to protection against congenital toxoplasmosis in mice (70% reduction in parasite load) and chronic toxoplasmosis in ewes (no parasite detected) correlated with strong and long-lasting humoral and Th1/Th17 cellular responses. We now apply this vaccine strategy against an emerging cause of abortion and infertility problems in cattle, neosporosis due to Neospora caninum. TLR ligands are added as adjuvant to reach sterilizing vaccine

Toxoplasmose et alimentation : un risque sous-estimé

National audienc

Glycolipids are potential targets for protozoan parasite diseases

International audienceInduction of sterilizing immunity by vaccination is extremely difficult because of the evasion mechanisms developed by parasites, and identification of new targets for therapy is therefore important. Glycosylphosphatidylinositols (GPIs) of parasites are glycolipids that participate in pathogenicity of parasitic diseases. Studies of Plasmodium falciparum and Trypanosoma brucei indicate that GPIs are good candidates for developing vaccines against malaria and sleeping sickness, respectively. By contrast, fatty acids isolated from P. falciparum and Toxoplasma gondii can inhibit the production of inflammatory cytokines induced by the GPIs in macrophages. GPIs are considered to be toxins that, if present in large amounts, induce irreversible damages to the host, and treatment with fatty acids could reduce this effect

Novel vaccines against T. gondii in mice and ewes

International audiencePrimary infection of pregnant ewes with Toxoplasma gondii leads to abortion and significant economic losses for the livestock industry. Moreover, infected animals constitute the main parasitic reservoir for humans, since the meat is commonly eaten undercooked. Therefore, the development of a one-health vaccine seems the best prevention strategy. A vaccine constituted of total extract (TE) of Toxoplasma gondii proteins incorporated into biodegradable maltodextrin-based nanoparticles (DGNP) has been developed. This DGNP/TE platform induces specific Th1/Th17 cellular immune responses and vaccination led to 100% survival of mice with acute toxoplasmosis and to significant reduction in the number of brain cysts of mice with chronic toxoplasmosis or of offspring born to immunized mice infected during pregnancy (1). In ewes, immunization with DGNP/TE vaccine generated specific Th1-cellular immune response (2). No cerebral cyst could be detected in ewes after infection with T. gondii and vertical transmission ofthe parasite to lambs was drastically reduced (88%). Thus, DGNP/TE vaccine administered by the nasal route conferred a high level of protection against latent toxoplasmosis and its transplacental transmission in sheep, highlighting the potential for development of such a vaccine for studies in other species